A new study suggests that high doses of vitamin D supplements could help reduce disease activity among multiple sclerosis ...
Treatment with tolebrutinib led to greater confirmed disability improvement at 6 months compared with placebo in patients ...
Walk MS is coming to Soldier Field April 27. Help fight multiple sclerosis. Register now for Walk MS at Soldier Field on ...
MUSETTE trial was designed to determine whether a higher dose of the currently approved OCREVUS IV 600 mg would provide ...
11d
MedPage Today on MSNDeciding Whether Multiple Sclerosis Treatment Should Be DiscontinuedObservational studies and two randomized controlled trials consistently suggest that, in general, disease recurrence after ...
No added benefits in slowing MS disability progression were found in a study that increased Ocrevus dosing to 2-3 times the ...
Explore more
2d
Khaleej Times on MSNUAE: From eyesight loss to career in healthcare; how these multiple sclerosis patients defy oddsDiscover how MS patients overcome challenges, raise awareness, and lead fulfilling careers in healthcare. Across the UAE, ...
A local naval officer is fearlessly facing his multiple sclerosis diagnosis, using his creativity and entrepreneurial skills ...
Fibrobiologics' cell therapy CYMS101 significantly increased myelin production and promoted myelin repair in a mouse model of MS ...
Researchers from CHU Nîmes, Université Montpellier, and multiple MS centers in France have found that oral cholecalciferol in ...
12d
Live Science on MSNIn a 1st, trial finds vitamin D supplements may slow multiple sclerosis. But questions remain.A new clinical trial has shown for the first time that taking high doses of vitamin D could stave off the progression of ...
Tom Nolan reviews this week’s research There are so many studies published about vitamin D—about a dozen each day—it’s hard to keep up. One that stands out is a double-blind randomised controlled ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results